← Open Payments lookup

BINDU KHANNA: Open Payments

NPI 1427004472 · HACKENSACK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,749 in 107 payments from 12 companies in 2025. Trend: 2023 $789 · 2024 $1,508 · 2025 $1,749

Food & beverage: $1,749
CompanyPaymentsAmount
Alkermes, Inc.24$438
Otsuka America Pharmaceutical, Inc.28$406
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$256
Teva Pharmaceuticals USA, Inc.14$192
Lundbeck LLC10$172
Janssen Pharmaceuticals, Inc6$101
Validus Pharmaceuticals LLC3$44
Neurocrine BioSciences, Inc.2$39
E.R. Squibb & Sons, L.L.C.2$35
Axsome Therapeutics, Inc.2$34

Products named: ARISTADA, ABILIFY ASIMTUFII, CAPLYTA, REXULTI, ABILIFY MAINTENA, INVEGA SUSTENNA, AUSTEDO XR, UZEDY.

Industry payments across NJ — which companies pay providers there.